16-1218385-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021098.3(CACNA1H):​c.5621C>T​(p.Ala1874Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,559,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A1874A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
12
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.07

Publications

10 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04415527).
BP6
Variant 16-1218385-C-T is Benign according to our data. Variant chr16-1218385-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 460148.
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5636C>T p.Ala1879Val missense_variant Exon 32 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5639C>T p.Ala1880Val missense_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5603C>T p.Ala1868Val missense_variant Exon 32 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5636C>T p.Ala1879Val missense_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5582C>T p.Ala1861Val missense_variant Exon 33 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5603C>T p.Ala1868Val missense_variant Exon 32 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5564C>T p.Ala1855Val missense_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5603C>T p.Ala1868Val missense_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5621C>T p.Ala1874Val missense_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5621C>T non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1573C>T non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*702C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3472C>T non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5065C>T non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*595C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*480C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1233C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*288C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*288C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5603C>T non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5621C>T non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5621C>T non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*737C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1573C>T 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*702C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3472C>T 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5065C>T 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*595C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*480C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1233C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*288C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*288C>T 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*737C>T 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152166
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000254
AC:
43
AN:
169590
AF XY:
0.000266
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00446
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000430
Gnomad OTH exome
AF:
0.000212
GnomAD4 exome
AF:
0.000112
AC:
157
AN:
1407630
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
84
AN XY:
695226
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31964
American (AMR)
AF:
0.00
AC:
0
AN:
36636
Ashkenazi Jewish (ASJ)
AF:
0.00462
AC:
117
AN:
25312
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79632
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.0000194
AC:
21
AN:
1084962
Other (OTH)
AF:
0.000307
AC:
18
AN:
58548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000986
AC:
15
AN:
152166
Hom.:
0
Cov.:
34
AF XY:
0.000108
AC XY:
8
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41426
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000428
Hom.:
0
Bravo
AF:
0.000159
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.000115
AC:
13

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hyperaldosteronism, familial, type IV Uncertain:1
May 09, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

CACNA1H-related disorder Benign:1
Jul 23, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Sep 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.059
T
BayesDel_noAF
Uncertain
-0.020
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.49
T;.;.;.
Eigen
Benign
0.11
Eigen_PC
Benign
-0.047
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D;D;D;.
M_CAP
Pathogenic
0.73
D
MetaRNN
Benign
0.044
T;T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.8
M;.;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.7
D;.;D;D
REVEL
Uncertain
0.47
Sift
Uncertain
0.0050
D;.;D;D
Sift4G
Uncertain
0.046
D;.;T;T
Polyphen
1.0
D;.;D;D
Vest4
0.49
MVP
0.95
ClinPred
0.31
T
GERP RS
3.1
Varity_R
0.34
gMVP
0.58
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374807892; hg19: chr16-1268385; COSMIC: COSV52357770; COSMIC: COSV52357770; API